Ames company working to develop ASF vaccine
Ames-based Genvax Technologies last week got a boost toward efforts to develop a safe and effective vaccine that protects against African swine fever (ASF), the deadly pig disease that has decimated hog herds around the world.
The vaccine company was awarded a $145,000 grant from the Foundation for Food & Agriculture Research (FFAR). Genvax will match the funds, putting a total of $290,000 toward the research.
“The threat posed by African swine fever is extraordinary to producers and consumers,” said Joel...
Members Only Content
Join Iowa Farm Bureau or login to view all members only content and receive other member benefits.